oldid148611

Erste: A&D Pharma's EBITDA margin could be lower than targeted

The EBITDA margin registered by the Romanian pharmaceutical company A&D Pharma could stand at 8.1% this year, against an initial target of 8.6%, according to Erste Bank analysts. "Given the overhead costs generated primarily by the company's international expa...